BIO-TECHNE ANNOUNCES SUBMISSION OF FDA DRUG MASTER FILE FOR

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it has filed a Drug Master File (DMF) with the U.S. Food and Drug Administration...

Related Keywords

David Clair , Investor Relations Corporate Development , Bio Techne Corporation , Drug Administration , Bio Techne Protein Sciences Segment , Prnewswire Bio Techne Corporation , Techne Corporation , Master File , Animal Free , Investigational New Drug , Will Geist , Protein Sciences , Vice President , Investor Relations ,